https://peptideindex.co.uk/studies/triple-hormone-receptor-agonist-retatrutide-for-obesity-a-phase-2-trial/2026-08-20T13:39:19+00:00https://peptideindex.co.uk/studies/retatrutide-gip-glp-1-glucagon-triple-agonist-in-type-2-diabetes-a-phase-2-trial/2026-08-20T13:39:19+00:00https://peptideindex.co.uk/studies/triumph-1-retatrutide-in-adults-with-obesity-phase-3/2026-08-20T13:39:19+00:00https://peptideindex.co.uk/studies/triumph-2-retatrutide-in-adults-with-type-2-diabetes-and-obesity-phase-3/2026-08-20T13:39:19+00:00https://peptideindex.co.uk/studies/once-weekly-cagrilintide-for-weight-management-a-phase-2-trial/2026-08-20T13:39:19+00:00https://peptideindex.co.uk/studies/cagrisema-cagrilintide-2-4-mg-semaglutide-2-4-mg-in-overweight-obesity-redefine-1/2026-08-20T13:39:19+00:00https://peptideindex.co.uk/studies/tirzepatide-once-weekly-for-the-treatment-of-obesity-surmount-1/2026-08-20T13:39:19+00:00https://peptideindex.co.uk/studies/tirzepatide-versus-semaglutide-once-weekly-in-type-2-diabetes-surpass-2/2026-08-20T13:39:19+00:00https://peptideindex.co.uk/studies/once-weekly-semaglutide-in-adults-with-overweight-or-obesity-step-1/2026-08-20T13:39:19+00:00https://peptideindex.co.uk/studies/tesamorelin-ghrh-analogue-for-excess-visceral-fat-in-hiv-lipodystrophy/2026-08-20T13:39:19+00:00https://peptideindex.co.uk/studies/elamipretide-in-primary-mitochondrial-myopathy-mmpower-3-phase-3/2026-08-20T13:39:19+00:00https://peptideindex.co.uk/studies/pentadecapeptide-bpc-157-promotes-tendon-healing-animal-model/2026-08-20T13:39:19+00:00